Emergency Medicine and Toxicology are critical fields within Thailand'班荔留晚s healthcare system, providing essential services for the timely diagnosis and treatment of urgent medical conditions. Against this backdrop, EDAN’s participation at the 46th AMTT 2024 in Bangkok has marked a significant milestone in advancing these vital medical disciplines.

At AMTT 2024, a leading laboratory and medical device exhibition, EDAN hosted an insightful workshop titled Unlocking th略毕e Hidden Secrets of Blood: CO-oximetry’s Role in Diagnosing Hemoglobin Disorders. This event, led by Assist. Prof. Thapanawong Mitsungnern, MD, from Khon Kaen University, drew over 300 professionals eager to explore cutting-edge advancements in laboratory technology. Dr. Mitsungnern, a respected expert in Emergency Medicine and Toxicology, shared his expertise on the role of CO-oximetry in enhancing diagnostic accuracy.

During the event, Dr. Mitsungnern discussed the importance of co-oximetry in identifying and treating hemoglobin disorders. He elaborated on how co-oximetry offers a detailed evaluation of a patient'勤佃叼谅s oxygenation levels by distinguishing between functional and dysfunctional hemoglobins. Dr. Mitsungnern pointed out that co-oximetry not only enhances diagnostic precision but also improves patient care through timely and targeted medical interventions.

The centerpiece of the workshop was the introduction of EDAN’s innovative blood gas and chemistry analyzer, the i20. This pioneering device is the world’s first Point-of-Care Testing (POCT) system to incorporate CO-oximetry para公垒meters, setting a new benchmark in blood analysis. The i20 features an optical fluorescence-based system supporting over 40 parameters in a single cartridge, delivering comprehensive results with exceptional precision in just two minutes. Its 10-inch, high-definition screen and user-friendly interface make it an invaluable tool for medical professionals.

CO-oximetry, as explained during the workshop, is an advanced analyt袁勺ical technique vital for measuring various blood hemoglobin derivatives such as oxyhemoglobin (HbO2), deoxyhemoglobin (HHb), carboxyhemoglobin (COHb), and methemoglobin (MetHb). This method provides a thorough assessment of a patient’s oxygenation status by distinguishing between functional and dysfunctional hemoglobins. Such precise measurements are essential for accurately diagnosing and managing conditions like carbon monoxide poisoning, methemog鸽疾lobinemia, and other hemoglobinopathies. By offering detailed insights into the different forms of hemoglobin, CO-oximetry aids in making informed management decisions in acute, inpatient, pediatric, and critical care settings.

The practical applications of the i20 analyzer extend beyond its advanced features, accurate and rapid testing capabilities. In Thailand, the i20 has been successfully installed in several prestigious healthcare facilities, enhancing clinical workflows and patient outcomes. Phyathai 2 Hospital, part of Bangkok Dusit Medical Services (BDMS), Thailand'凯书s largest private medical group, Vejthani Hospital, a JCI-accredited private quaternary hospital serving over 300,000 international patients from more than 100 countries annually, and Vajira Hospital, one of Bangkok'仙亡s finest centers for Emergency Medicine, are among the esteemed institutions utilizing the EDAN blood gas analyzer.

EDAN'谁帕槐瑞s achievements in Thailand underscore its commitment to advancing healthcare in the Asia Pacific region. The deployment of the i20 in leading hospitals highlights the company's role in improving patient outcomes and enhancing the quality of medical diagnostics. As EDAN continues to innovate in the field of Point-of-Care Testing, its contributions are poised to make a lasting and positive impact on healthcare practices, ensuring better health and well-being for patients across the region.